Pear Therapeutics
The latest funding was led by Temasek, with participation from Novartis, 5AM Ventures, Arboretum Ventures, Jazz Partners, The Bridge Builders Collaborative and EDBI.
The prescription digital therapeutic will give users interactive therapy lessons to be use by patients under a clinician's supervision.
A new innovation center called the Biome and numerous internal efforts paint a picture of a digital-focused game plan.
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.
The definition is broad, but an accompanying whitepaper attempts to pin down the category's place in the industry.
A collaborative attitude and a commitment to strenuous review have characterized the process so far.
At the Digital Health Innovation Summit in Boston, experts said early digital therapeutics companies have an opportunity to sculpt the space.
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston.
From syringes to workflow management systems, healthcare is no stranger to adopting new technologies into standard care.
Pear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia.